0 NASDAQ Companies - September 4, 2019AC Immune Awarded Michael J. Fox Foundation Grant to Accelerate Development of Parkinson’s Disease Diagnostic Imaging AgentRead More
0 NASDAQ Companies - September 4, 2019Athenex Announces Appointment of Daniel Lang MD to Lead TCR-T Immunotherapy Operations and Support Corporate Development StrategyRead More
0 NASDAQ Companies - September 4, 2019Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2019Read More
0 NASDAQ Companies - September 4, 2019Idera Pharmaceuticals Announces Immuno-Oncology Clinical Research Collaboration with AbbVieRead More
0 NASDAQ Companies - September 4, 2019Tonix Pharmaceuticals Doses Participants in Phase 1 Study Evaluating TNX-601 for the Daytime Treatment of Posttraumatic Stress DisorderRead More
0 NASDAQ Companies - September 4, 2019Fulcrum Therapeutics Appoints Pamela Strode, Seasoned Industry Executive, to Lead Regulatory Affairs TeamRead More
0 NASDAQ Companies - September 4, 2019Orchard Therapeutics Presents an Integrated Data Analysis Demonstrating Sustained Clinical Benefit of OTL-200 for the Treatment of Metachromatic LeukodystrophyRead More
0 NASDAQ Companies - September 4, 2019Cyclacel Pharmaceuticals to Present at the 21st Annual H.C. Wainwright Global Investment Conference Read More
0 NASDAQ Companies - September 4, 2019Auris Medical Announces Appointment of New Chief Financial OfficerRead More
0 NASDAQ Companies - September 4, 2019Summit Therapeutics to Participate in Upcoming Investor ConferencesRead More
